RGEN

Repligen Stock Analysis

AI Rating

Low
  • Quality5/10
  • Growth 0/10
  • Momentum 4/10
Repligen sales and earnings growth
RGEN Growth
Low
  • Revenue Y/Y 11.74%
  • EPS Y/Y 114.29%
  • FCF Y/Y -22.86%
Repligen gross and profit margin trends
RGEN Profitability
Good
  • Gross margin 45.40%
  • EPS margin 0.20%
  • ROIC 2.20%
Repligen net debt vs free cash flow
RGEN Risk
Great
  • Debt / Equity 0.3
  • Debt / FCF 0.0
  • Interest coverage 1.2

Repligen stock volatility is in-line with the overall market. We give it a Great risk rating.

More Medical Instruments & Supplies stocks ↗